Shares of Nu Skin got hammered earlier in the week after a report from a well-known short-selling firm Citron Research came out questioning the viability of the company's operations in China. Andrew Left, Citron Research, and Bill Schmitz, Deutsche Bank senior research analyst, discuss.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT